Hyaron® Skin Booster – 10 × 2.5ml | Sodium Hyaluronate

Hyaron® Skin Booster – 10 × 2.5ml | Sodium Hyaluronate

Product Overview

Hyaron® is a professional non-cross-linked Sodium Hyaluronate skin booster developed to provide intensive skin hydration, biorevitalisation and overall improvement in skin quality.

Manufactured by Dongkook Pharmaceutical in South Korea, Hyaron® contains highly purified Sodium Hyaluronate produced through microbial fermentation and is designed for professional injectable skin-rejuvenation treatments.

Each 2.5ml pre-filled syringe contains 25mg of Sodium Hyaluronate, providing a lightweight, hydrating formulation designed to integrate within the skin without the structural volumising characteristics associated with cross-linked dermal fillers.

Unlike traditional cross-linked Hyaluronic Acid fillers, which are typically designed to create volume, projection or facial contour, Hyaron® focuses primarily on hydration and skin-quality improvement.

The non-cross-linked Sodium Hyaluronate helps replenish moisture within the skin and supports improvements in:

• Skin hydration

• Moisture retention

• Skin elasticity

• Skin smoothness

• Dermal suppleness

• Skin texture

• Skin radiance

• Overall skin quality

Its lightweight formulation makes Hyaron® particularly suited to professional mesotherapy and skin-rejuvenation protocols for patients experiencing dry, dehydrated or ageing skin.

Rather than changing facial structure, Hyaron® is intended to support healthier-looking, smoother and more hydrated skin while maintaining natural facial contours.

Hyaron® is intended strictly for use by appropriately qualified medical or aesthetic professionals trained in injectable skin-rejuvenation procedures.

Pack Contents

Each pack contains:

• 10 × 2.5ml pre-filled sterile syringes of Hyaron®

• 25mg Sodium Hyaluronate per syringe

• Sterile professional-use packaging

• Single-use syringes

Volume per Syringe: 2.5ml

Total Pack Volume: 25ml

Sodium Hyaluronate per Syringe: 25mg

Sodium Hyaluronate Concentration: 10mg/ml

Always check the individual product packaging, manufacturer labelling and current Instructions for Use before administration.

Product CompositionSodium Hyaluronate – 25mg / 2.5ml

The principal component of Hyaron® is non-cross-linked Sodium Hyaluronate.

Each 2.5ml syringe contains:

25mg Sodium Hyaluronate

Equivalent to:

10mg/ml Sodium Hyaluronate

Sodium Hyaluronate is the sodium salt of Hyaluronic Acid and is recognised for its ability to bind and retain water.

Within Hyaron®, the non-cross-linked Sodium Hyaluronate is designed primarily to support skin hydration and overall dermal quality rather than create structural facial volume.

It may support:

• Improved skin hydration

• Increased moisture retention

• Improved skin elasticity

• Improved skin smoothness

• Enhanced dermal suppleness

• Healthier-looking skin

• Improved overall skin quality

Sodium Chloride

Sodium Chloride forms part of the formulation and helps maintain appropriate physiological osmolarity while contributing to product stability.

Monobasic Sodium Phosphate

Monobasic Sodium Phosphate forms part of the product's buffering system and helps maintain an appropriate pH and formulation stability.

Water for Injection

Sterile Water for Injection provides the carrier solution for the formulation.

Non-Cross-Linked Hyaluronic Acid Technology

One of the defining characteristics of Hyaron® is its use of non-cross-linked Sodium Hyaluronate.

Cross-linking is commonly used in structural Hyaluronic Acid dermal fillers to increase gel persistence and provide properties suitable for volume, projection and contouring.

Hyaron® takes a different approach.

Its non-cross-linked formulation is designed primarily to disperse within the treated tissue and support hydration rather than create substantial physical volume.

This makes the treatment more appropriate for skin-quality objectives such as:

• Hydration

• Smoothness

• Elasticity

• Suppleness

• Texture

• Radiance

The primary objective is therefore biorevitalisation and skin-quality improvement rather than facial augmentation.

Skin Hydration & Biorevitalisation

Hyaluronic Acid is naturally present within the skin and extracellular matrix, where it plays an important role in hydration and tissue homeostasis.

Its ability to attract and retain water contributes to the skin's:

• Hydration

• Elasticity

• Suppleness

• Smoothness

• Overall appearance

Changes associated with ageing and environmental exposure can contribute to reduced hydration and deterioration in overall skin quality.

This may present as:

• Dryness

• Dehydration

• Dull-looking skin

• Reduced elasticity

• Rougher texture

• Reduced suppleness

• Fine dehydration lines

Hyaron® is designed to replenish hydration within the skin using non-cross-linked Sodium Hyaluronate.

By supporting moisture levels within the treated tissue, Hyaron® may contribute to smoother, softer and more radiant-looking skin.

Moisture Retention

Sodium Hyaluronate has strong water-binding properties.

Following appropriate professional administration, the Sodium Hyaluronate within Hyaron® helps support moisture retention within the treated tissue.

Improved hydration may contribute to:

• Softer-feeling skin

• Smoother-looking texture

• Improved elasticity

• Greater suppleness

• Improved radiance

• Reduced appearance of dehydration-related fine lines

• Healthier-looking skin

Because Hyaron® is non-cross-linked, the treatment should not be approached as a structural replacement for a conventional dermal filler.

Key Benefits

• Professional non-cross-linked Sodium Hyaluronate skin booster

• Manufactured by Dongkook Pharmaceutical

• Manufactured in South Korea

• 10 × 2.5ml pre-filled syringes

• 25ml total pack volume

• 25mg Sodium Hyaluronate per syringe

• Equivalent to 10mg/ml Sodium Hyaluronate

• Designed for intensive skin hydration

• Supports moisture retention

• Helps improve skin elasticity

• Supports smoother-looking skin

• Helps improve skin texture

• Supports dermal suppleness

• Helps improve skin radiance

• May reduce the appearance of dehydration-related fine lines

• Designed for skin biorevitalisation

• Suitable for professional mesotherapy protocols where indicated

• Suitable for general skin-rejuvenation protocols

• Non-cross-linked formulation

• Does not primarily provide structural facial volume

• Supports natural-looking skin rejuvenation

• Intended strictly for appropriately qualified professional use

Common Treatment Areas

Following appropriate consultation and professional assessment, Hyaron® may be incorporated into skin-rejuvenation protocols involving:

• Full face

• Neck

• Décolletage

• Back of the hands

• Perioral region

• Forehead

• Cheeks

• Chin

• Jawline

• Areas demonstrating dry skin

• Areas demonstrating dehydration

• Areas demonstrating age-related deterioration in skin quality

Treatment area suitability should always be determined according to the patient's individual anatomy, skin condition, medical history and treatment objectives.

Always follow the manufacturer's current Instructions for Use regarding approved indications, administration technique, treatment depth, product volume and placement.

Hyaron® vs Cross-Linked Dermal Fillers

Hyaron® should not be considered equivalent to a conventional cross-linked Hyaluronic Acid dermal filler.

Cross-Linked HA Dermal Fillers

These products are generally designed to provide:

• Physical volume

• Projection

• Structural support

• Facial contouring

• Correction of selected wrinkles and folds

Hyaron®

Hyaron® is designed primarily to support:

• Skin hydration

• Moisture retention

• Skin elasticity

• Dermal suppleness

• Skin smoothness

• Skin texture

• Skin radiance

• Overall skin quality

Its primary objective is therefore skin hydration and biorevitalisation rather than structural augmentation.

Hyaron® vs Polynucleotide Skin Boosters

Hyaron® also differs from Polynucleotide or PDRN-based regenerative skin boosters.

Hyaron®

The principal active component is:

Non-cross-linked Sodium Hyaluronate

Its primary treatment focus is:

• Hydration

• Moisture retention

• Elasticity

• Smoothness

• Skin biorevitalisation

PN / PDRN Skin Boosters

Polynucleotide-based products are typically positioned around regenerative mechanisms such as:

• Fibroblast support

• Tissue regeneration

• Extracellular matrix support

• Collagen-related regenerative activity

Hyaron® therefore provides an option where the primary treatment objective is HA-based hydration and general skin revitalisation.

Recommended Treatment Course

Hyaron® should only be administered by practitioners appropriately trained in professional injectable skin-rejuvenation procedures.

A commonly referenced treatment approach described in the supplied product information is:

• Initial Course: 3 treatment sessions

• Treatment Interval: Approximately every 3–4 weeks

• Maintenance: Approximately every 3–6 months, depending upon skin condition and clinical response

These intervals should not be considered a universal or mandatory protocol.

The appropriate treatment schedule should be individually determined according to:

• Patient age

• Baseline skin condition

• Degree of dehydration

• Skin elasticity

• Treatment area

• Medical history

• Previous aesthetic procedures

• Clinical response

• Individual treatment objectives

The manufacturer's current Instructions for Use should always take precedence over commonly referenced treatment schedules.

Professional Treatment Considerations

Hyaron® is intended for administration by appropriately qualified and trained medical or aesthetic professionals with suitable knowledge of injectable skin-rejuvenation procedures.

Treatment planning should include:

• Comprehensive medical consultation

• Review of medical history

• Assessment of skin quality

• Assessment of hydration levels

• Evaluation of the proposed treatment area

• Review of previous aesthetic procedures

• Assessment of contraindications

• Discussion of realistic treatment expectations

• Explanation of potential adverse effects and complications

• Completion of appropriate documented informed consent

Injection technique, treatment depth, product volume and distribution should always be determined according to individual anatomy, skin condition, practitioner assessment and the manufacturer's current Instructions for Use.

Hyaron® should not be administered using a generic protocol without appropriate consideration of patient-specific factors.

Results & Treatment Outcomes

Hyaron® is designed primarily to support hydration and overall skin-quality improvement.

Patients may notice improvements in skin hydration and luminosity as moisture levels within the treated tissue increase.

Potential treatment outcomes may include:

• Improved skin hydration

• Improved moisture retention

• Better skin elasticity

• Smoother-looking skin

• Improved skin texture

• Increased suppleness

• Improved radiance

• Healthier-looking skin

• Reduction in the appearance of dehydration-related fine lines

A professionally planned course of treatment may be used where progressive improvement in skin hydration and overall quality is desired.

As Hyaron® contains non-cross-linked Sodium Hyaluronate, maintenance treatment may subsequently be considered to support ongoing skin hydration.

Individual outcomes vary according to:

• Patient age

• Baseline skin condition

• Degree of dehydration

• Treatment area

• Number of sessions

• Treatment interval

• Practitioner technique

• Lifestyle

• Individual biological response

No specific duration of effect should be guaranteed.

Storage & Handling

Hyaron® should be stored according to the manufacturer's current recommendations and the information supplied with the original product.

To maintain product integrity:

• Keep unused product within its original packaging.

• Store in a cool, dry place in accordance with manufacturer guidance.

• Protect from direct sunlight.

• Inspect each syringe and the outer packaging before use.

• Check the batch number and expiry date.

• Verify product authenticity and traceability.

• Maintain appropriate aseptic handling procedures.

• Do not use if sterile packaging is damaged.

• Do not use if the syringe appears compromised.

• Do not use after the stated expiry date.

Each syringe is intended for single use according to the manufacturer's Instructions for Use.

Important Information

Hyaron® is intended strictly for use by appropriately qualified and trained medical or aesthetic professionals.

Professional knowledge of the following is essential:

• Relevant facial and treatment-area anatomy

• Injectable skin-rejuvenation techniques

• Mesotherapy techniques where applicable

• Appropriate treatment planes

• Patient selection

• Aseptic practice

• Complication prevention

• Adverse-event recognition

• Appropriate complication management

Patient Assessment

Treatment should only proceed following:

• Full medical consultation

• Review of medical history

• Assessment of skin condition

• Examination of the proposed treatment area

• Review of previous aesthetic procedures

• Assessment of contraindications

• Discussion of expected outcomes

• Explanation of potential adverse effects and complications

• Completion of appropriate documented informed consent

Contraindications & Precautions

According to the supplied information, treatment may be unsuitable for individuals with:

• Active infection or inflammation within the proposed treatment area

• Pregnancy or breastfeeding

• Bleeding disorders

• Active dermatological conditions

• Known hypersensitivity to any product component

• Impaired wound healing

• Recent cosmetic procedures requiring an appropriate healing interval

• Other contraindications identified during professional assessment

This list should not be considered exhaustive.

Always consult the manufacturer's current Instructions for Use for the complete contraindication, warning and precaution profile.

Potential Treatment Reactions

Temporary treatment-related effects may include:

• Redness

• Swelling

• Bruising

• Tenderness

• Mild discomfort

• Temporary injection-site papules

• Localised itching

These effects are generally associated with injectable procedures; their incidence and duration may vary.

More significant complications may also occur with injectable aesthetic treatments.

The supplied information references potential complications including:

• Infection

• Delayed inflammatory reactions

• Vascular compromise

• Tissue injury

Practitioners should be appropriately trained in complication recognition and management and provide patients with comprehensive written aftercare instructions.

Always consult the manufacturer's current Instructions for Use for complete information regarding indications, contraindications, warnings, precautions, administration and potential adverse events.

Do not use the product where:

• Sterile packaging is damaged

• A syringe appears compromised

• The product has passed its expiry date

• Product integrity is in doubt

• Authenticity or traceability cannot be established

For appropriately qualified professional use only.